BPA Call W81K0222A0010-HT009024FG0570023

Award Date 5/7/24
Potential Completion Date 9/30/24
Potential Value $74K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bassett, CA 91746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. for the provision of breastmilk fortification products for use in neonatal intensive care units (NICUs). The contract has a ceiling value of $24,838.83 and a performance period through September 30, 2025. No set-aside was used for this award. Prolacta Bioscience is a for-profit manufacturer that specializes in human milk-based nutritional products...
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. to purchase Prolacta's human milk-based nutritional products for premature infants in military medical facilities. The contract has a total ceiling value of $24,838.69 and a period of performance through September 30, 2024. Prolacta Bioscience is a for-profit manufacturer that specializes in providing human milk-based products to support the care of...
This contract was awarded to Prolacta Bioscience, Inc. by the Department of the Army Medical Command. The contract, valued at $150,000.00, is for the provision of human milk-based neonatal nutrition products to support premature and critically ill infants treated at military medical facilities. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and a performance period ending on September 30, 2022. Prolacta Bioscience, a manufacturer of goods, has...
This federal contract award to Prolacta Bioscience, Inc. is for the procurement of PROLACT+6 HMF, which are human milk-based nutritional products primarily for premature and critically ill infants in military medical facilities. The $3,254,150.28 firm fixed price contract, awarded by the Defense Health Agency (DHA), has an ultimate completion date of September 30, 2024. This award is part of three significant federal contract indefinite delivery vehicles (IDVs) held by Prolacta Bioscience with...
This is a firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products. The $585,870.20 contract is to provide human milk fortifiers to the San Antonio Military Medical Center at Fort Sam Houston, Texas. The award has a set-aside designation for small businesses and a period of performance through September 30, 2019. Prolacta Bioscience is a leading provider of...
This is a $96,228 firm fixed price purchase order awarded by the U.S. Army Medical Command to Prolacta Bioscience, Inc. for PROLACTA+6 H2MF 30 ML (93901-30) human milk-based nutritional products. The award has an ultimate completion date of December 31, 2018 and was made on October 11, 2018. Prolacta Bioscience is a for-profit manufacturer that specializes in human milk-based therapies for premature and critically ill infants in neonatal intensive care units. This contract is not associated with...
This is a Blanket Purchase Agreement (BPA) call order awarded by the Defense Logistics Agency (DLA) Troop Support Pacific to At Fresh Pte. LTD., a for-profit limited liability company based in Singapore. The $1,851.30 firm fixed-price contract is for the delivery of shelf-stable, reduced/low-fat milk to support U.S. military operations in the Pacific region. This BPA call order is part of a larger $150,000 IDIQ BPA established in October 2022, which allows At Fresh Pte. LTD. to serve as a...
This is a Firm Fixed Price delivery order contract awarded by the Pacific Air Forces (PACAF) agency to Medical North America JV, a for-profit limited liability company. The contract is for the provision of 1 full-time equivalent (FTE) lactation consultant and has a ceiling value of $331,298.14. The contract is part of the AFMS Clinical Acquisition for Support Services Program (AFMS CLASS) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The contract does not have a set-aside...
This firm-fixed-price blanket purchase agreement (BPA) call was awarded by the Defense Health Agency (DHA) to Abbott Laboratories' Abbott Nutrition division for the delivery of nutritional supplements for clinical use. The contract has a ceiling value of $23,464.08 and a period of performance ending on September 30, 2017. This award was not set aside for small businesses. Abbott Laboratories is a large, for-profit manufacturer of medical devices, pharmaceuticals, and nutritional products, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Owens & Minor Distribution Inc., a subsidiary of Owens & Minor Inc., for the delivery of Similac Human Milk Fortifier Liquid. The contract has a ceiling value of $1,471.50 and was awarded on December 29, 2017, with a completion date of January 19, 2018. The contract is a Delivery Order under Owens & Minor's Indefinite Delivery Contract (IDC) with the DLA, specifically the SPE2DV contract valued at up to...
  • W81K0222A0010
    Blanket Purchase Agreement
  • W81K0222A0010-HT009024FG0570023
    BPA Call

This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc., a for-profit manufacturer of human milk-based nutritional products. The contract is for the provision of breastmilk fortification products for use with extremely premature infants in neonatal intensive care units. The total ceiling value of the contract is $74,175.11, with a period of performance through September 30, 2024. Prolacta Bioscience holds two active indefinite delivery vehicles with the DHA, one for $250,000 in donor human milk and another for $1.75 million in various human milk-based products. This contract is not subject to any set-aside requirements.

Generated 8/6/24, 11:08 AM